BIO RAD LABS INC's ticker is BIOB and the CUSIP is 090572108. A total of 8 filers reported holding BIO RAD LABS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $257,064 | -5.6% | 724 | 0.0% | 0.00% | – |
| Q2 2023 | $272,268 | -20.7% | 724 | 0.0% | 0.00% | – |
| Q1 2023 | $343,220 | +15.1% | 724 | 0.0% | 0.00% | – |
| Q4 2022 | $298,288 | -1.2% | 724 | 0.0% | 0.00% | – |
| Q3 2022 | $302,000 | -15.6% | 724 | 0.0% | 0.00% | – |
| Q2 2022 | $358,000 | -8.0% | 724 | +4.6% | 0.00% | – |
| Q1 2022 | $389,000 | -25.5% | 692 | 0.0% | 0.00% | – |
| Q4 2021 | $522,000 | +1.6% | 692 | 0.0% | 0.00% | – |
| Q3 2021 | $514,000 | +16.0% | 692 | 0.0% | 0.00% | – |
| Q2 2021 | $443,000 | +12.4% | 692 | 0.0% | 0.00% | – |
| Q1 2021 | $394,000 | -2.2% | 692 | 0.0% | 0.00% | – |
| Q4 2020 | $403,000 | +14.2% | 692 | 0.0% | 0.00% | – |
| Q3 2020 | $353,000 | +11.4% | 692 | -1.4% | 0.00% | – |
| Q2 2020 | $317,000 | +74.2% | 702 | +34.5% | 0.00% | – |
| Q1 2020 | $182,000 | -5.7% | 522 | 0.0% | 0.00% | – |
| Q4 2019 | $193,000 | +11.6% | 522 | 0.0% | 0.00% | – |
| Q3 2019 | $173,000 | +6.1% | 522 | 0.0% | 0.00% | – |
| Q2 2019 | $163,000 | +28.3% | 522 | -5.1% | 0.00% | – |
| Q4 2018 | $127,000 | -49.2% | 550 | -31.2% | 0.00% | – |
| Q3 2018 | $250,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 7,375 | $4,299,000 | 0.16% |
| Gemmer Asset Management LLC | 299 | $174,000 | 0.03% |
| Renaissance Technologies | 2,900 | $1,665,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 692 | $403,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 51 | $30,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 56 | $33,000 | 0.00% |